Works matching IS 1756283X AND DT 2016 AND VI 9 AND IP 4
Results: 19
The clinical potential of etrolizumab in ulcerative colitis: hypes and hopes.
- Published in:
- Therapeutic Advances in Gastroenterology, 2016, v. 9, n. 4, p. 503, doi. 10.1177/1756283X16647935
- By:
- Publication type:
- Article
Ipilimumab-induced colitis: experience from a tertiary referral center.
- Published in:
- Therapeutic Advances in Gastroenterology, 2016, v. 9, n. 4, p. 457, doi. 10.1177/1756283X16646709
- By:
- Publication type:
- Article
Neoadjuvant therapy for pancreatic cancer: an ongoing debate.
- Published in:
- Therapeutic Advances in Gastroenterology, 2016, v. 9, n. 4, p. 429, doi. 10.1177/1756283X16646524
- By:
- Publication type:
- Article
Probiotics modify tight-junction proteins in an animal model of nonalcoholic fatty liver disease.
- Published in:
- Therapeutic Advances in Gastroenterology, 2016, v. 9, n. 4, p. 463, doi. 10.1177/1756283X16645055
- By:
- Publication type:
- Article
Endoscopic ultrasound-assisted gastrointestinal hemostasis: an evolving technique.
- Published in:
- Therapeutic Advances in Gastroenterology, 2016, v. 9, n. 4, p. 635, doi. 10.1177/1756283X16645050
- By:
- Publication type:
- Article
Cost-effectiveness analysis of rifaximin-α administration for the reduction of episodes of overt hepatic encephalopathy in recurrence compared with standard treatment in France.
- Published in:
- Therapeutic Advances in Gastroenterology, 2016, v. 9, n. 4, p. 473, doi. 10.1177/1756283X16644249
- By:
- Publication type:
- Article
Predictors of pain response in patients undergoing endoscopic ultrasound-guided neurolysis for abdominal pain caused by pancreatic cancer.
- Published in:
- Therapeutic Advances in Gastroenterology, 2016, v. 9, n. 4, p. 483, doi. 10.1177/1756283X16644248
- By:
- Publication type:
- Article
Epigenetic therapy in gastrointestinal cancer: the right combination.
- Published in:
- Therapeutic Advances in Gastroenterology, 2016, v. 9, n. 4, p. 560, doi. 10.1177/1756283X16644247
- By:
- Publication type:
- Article
The intestinal microbiome, barrier function, and immune system in inflammatory bowel disease: a tripartite pathophysiological circuit with implications for new therapeutic directions.
- Published in:
- Therapeutic Advances in Gastroenterology, 2016, v. 9, n. 4, p. 606, doi. 10.1177/1756283X16644242
- By:
- Publication type:
- Article
Low-dose azathioprine is effective in maintaining remission in steroid-dependent ulcerative colitis: results from a territory-wide Chinese population-based IBD registry.
- Published in:
- Therapeutic Advances in Gastroenterology, 2016, v. 9, n. 4, p. 449, doi. 10.1177/1756283X16643509
- By:
- Publication type:
- Article
Current approaches for optimizing the benefit of biologic therapy in ulcerative colitis.
- Published in:
- Therapeutic Advances in Gastroenterology, 2016, v. 9, n. 4, p. 548, doi. 10.1177/1756283X16643242
- By:
- Publication type:
- Article
Understanding the gastrointestinal manifestations of Fabry disease: promoting prompt diagnosis.
- Published in:
- Therapeutic Advances in Gastroenterology, 2016, v. 9, n. 4, p. 626, doi. 10.1177/1756283X16642936
- By:
- Publication type:
- Article
Stem cell-based therapies in inflammatory bowel disease: promises and pitfalls.
- Published in:
- Therapeutic Advances in Gastroenterology, 2016, v. 9, n. 4, p. 533, doi. 10.1177/1756283X16642190
- By:
- Publication type:
- Article
Predicting durable response or resistance to antitumor necrosis factor therapy in inflammatory bowel disease.
- Published in:
- Therapeutic Advances in Gastroenterology, 2016, v. 9, n. 4, p. 513, doi. 10.1177/1756283X16638833
- By:
- Publication type:
- Article
Novel perspectives on therapeutic modulation of the gut microbiota.
- Published in:
- Therapeutic Advances in Gastroenterology, 2016, v. 9, n. 4, p. 580, doi. 10.1177/1756283X16637819
- By:
- Publication type:
- Article
The association between socioeconomic status and the symptoms at diagnosis of celiac disease: a retrospective cohort study.
- Published in:
- Therapeutic Advances in Gastroenterology, 2016, v. 9, n. 4, p. 495, doi. 10.1177/1756283X16637532
- By:
- Publication type:
- Article
Mongersen, an oral Smad7 antisense oligonucleotide, in patients with active Crohn’s disease.
- Published in:
- Therapeutic Advances in Gastroenterology, 2016, v. 9, n. 4, p. 527, doi. 10.1177/1756283X16636781
- By:
- Publication type:
- Article
The interplay between the microbiome and the adaptive immune response in cancer development.
- Published in:
- Therapeutic Advances in Gastroenterology, 2016, v. 9, n. 4, p. 594, doi. 10.1177/1756283X16635082
- By:
- Publication type:
- Article
Systematic review: third-line susceptibility-guided treatment for Helicobacter pylori infection.
- Published in:
- Therapeutic Advances in Gastroenterology, 2016, v. 9, n. 4, p. 437, doi. 10.1177/1756283X15621229
- By:
- Publication type:
- Article